The store will not work correctly when cookies are disabled.
5-((3-chlorophenoxy)methyl)-3-phenyloxazolidin-2-one
ID: ALA1097984
PubChem CID: 46887417
Max Phase: Preclinical
Molecular Formula: C16H14ClNO3
Molecular Weight: 303.75
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1OC(COc2cccc(Cl)c2)CN1c1ccccc1
Standard InChI: InChI=1S/C16H14ClNO3/c17-12-5-4-8-14(9-12)20-11-15-10-18(16(19)21-15)13-6-2-1-3-7-13/h1-9,15H,10-11H2
Standard InChI Key: ORGHBKVIGSUKOS-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
6.4124 -3.4662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2375 -3.4667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4943 -2.6826 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.8250 -2.1958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1599 -2.6826 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.0022 -4.1820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1772 -4.1845 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.7669 -4.9003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8237 -1.3708 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.2035 -2.2656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9202 -2.6766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6323 -2.2616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6290 -1.4357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9076 -1.0266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1985 -1.4440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9411 -4.8999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5309 -5.6148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9456 -6.3289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7749 -6.3237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1814 -5.6082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1921 -7.0354 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
10 11 2 0
1 2 1 0
11 12 1 0
1 6 1 0
12 13 2 0
13 14 1 0
6 7 1 0
14 15 2 0
15 10 1 0
3 10 1 0
2 3 1 0
8 16 2 0
7 8 1 0
16 17 1 0
3 4 1 0
17 18 2 0
4 9 2 0
18 19 1 0
4 5 1 0
19 20 2 0
20 8 1 0
5 1 1 0
19 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 303.75 | Molecular Weight (Monoisotopic): 303.0662 | AlogP: 3.74 | #Rotatable Bonds: 4 |
Polar Surface Area: 38.77 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.83 | CX LogD: 3.83 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.86 | Np Likeness Score: -1.25 |
References
1. Brnardic EJ, Fraley ME, Garbaccio RM, Layton ME, Sanders JM, Culberson C, Jacobson MA, Magliaro BC, Hutson PH, O'Brien JA, Huszar SL, Uslaner JM, Fillgrove KL, Tang C, Kuo Y, Sur SM, Hartman GD.. (2010) 3-Aryl-5-phenoxymethyl-1,3-oxazolidin-2-ones as positive allosteric modulators of mGluR2 for the treatment of schizophrenia: Hit-to-lead efforts., 20 (10): [PMID:20409708] [10.1016/j.bmcl.2010.03.089] |